Movement Alert｜Philip Morris Rises 3.02% in Regular Trading, Zyn Portfolio Expansion and Full-Year Guidance Upgrade Boost Sentiment

Market Focus

Sep 10

On September 10, Philip Morris rose 3.02% in regular trading, trading at $191.61/share, with turnover of $92.96 million. The rally was driven by a combination of Zyn product line expansion and a significant upward revision to full-year earnings guidance.

Philip Morris announced it has expanded its Zyn portfolio, adding new nicotine strengths of 1.5 mg and 8 mg to the existing 3 mg and 6 mg dry pouch lineup. The company also launched Zyn Ultra, an oral nicotine pouch with higher moisture content and free of tobacco leaf, and plans to adjust its 3 mg and 6 mg dry pouch variants to 20 pouches per can in Q4 to align with consumer preferences.

On September 8, the company raised its full-year adjusted EPS guidance to $8.35-$8.50, implying 10.7%-12.7% year-over-year growth, a notable increase from the $8.11-$8.26 range issued in July. The upgraded outlook follows Zyn products receiving FDA Modified Risk Tobacco Product orders and FDA authorization for ZYN ULTRA, strengthening the product matrix and reinforcing earnings momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/news/1125685563"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125685563\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125685563?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125685563","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Philip Morris Rises 3.02% in Regular Trading, Zyn Portfolio Expansion and Full-Year Guidance Upgrade Boost Sentiment","media":"Market Focus","content":"<p><p>On September 10, Philip Morris rose 3.02% in regular trading, trading at $191.61/share, with turnover of $92.96 million. The rally was driven by a combination of Zyn product line expansion and a significant upward revision to full-year earnings guidance.</p><p>Philip Morris announced it has expanded its Zyn portfolio, adding new nicotine strengths of 1.5 mg and 8 mg to the existing 3 mg and 6 mg dry pouch lineup. The company also launched Zyn Ultra, an oral nicotine pouch with higher moisture content and free of tobacco leaf, and plans to adjust its 3 mg and 6 mg dry pouch variants to 20 pouches per can in Q4 to align with consumer preferences.</p><p>On September 8, the company raised its full-year adjusted EPS guidance to $8.35-$8.50, implying 10.7%-12.7% year-over-year growth, a notable increase from the $8.11-$8.26 range issued in July. The upgraded outlook follows Zyn products receiving FDA Modified Risk Tobacco Product orders and FDA authorization for ZYN ULTRA, strengthening the product matrix and reinforcing earnings momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Philip Morris Rises 3.02% in Regular Trading, Zyn Portfolio Expansion and Full-Year Guidance Upgrade Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Philip Morris Rises 3.02% in Regular Trading, Zyn Portfolio Expansion and Full-Year Guidance Upgrade Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-10 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 10, Philip Morris rose 3.02% in regular trading, trading at $191.61/share, with turnover of $92.96 million. The rally was driven by a combination of Zyn product line expansion and a significant upward revision to full-year earnings guidance.</p><p>Philip Morris announced it has expanded its Zyn portfolio, adding new nicotine strengths of 1.5 mg and 8 mg to the existing 3 mg and 6 mg dry pouch lineup. The company also launched Zyn Ultra, an oral nicotine pouch with higher moisture content and free of tobacco leaf, and plans to adjust its 3 mg and 6 mg dry pouch variants to 20 pouches per can in Q4 to align with consumer preferences.</p><p>On September 8, the company raised its full-year adjusted EPS guidance to $8.35-$8.50, implying 10.7%-12.7% year-over-year growth, a notable increase from the $8.11-$8.26 range issued in July. The upgraded outlook follows Zyn products receiving FDA Modified Risk Tobacco Product orders and FDA authorization for ZYN ULTRA, strengthening the product matrix and reinforcing earnings momentum.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PM","symbol_name":"菲利普莫里斯","start_time":0,"source_url":"","article_id":"1125685563","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125685563","pubTimestamp":1789048127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 10, Philip Morris rose 3.02% in regular trading, trading at $191.61/share, with turnover of $92.96 million. The rally was driven by a combination of Zyn product line expansion and a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PM":"菲利普莫里斯"},"translate_title":"走势警报|菲利普莫里斯常规交易上涨 3.02%，Zyn 投资组合扩张和全年指引升级提振市场情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PM":1},"content_text":"On September 10, Philip Morris rose 3.02% in regular trading, trading at $191.61/share, with turnover of $92.96 million. The rally was driven by a combination of Zyn product line expansion and a significant upward revision to full-year earnings guidance.Philip Morris announced it has expanded its Zyn portfolio, adding new nicotine strengths of 1.5 mg and 8 mg to the existing 3 mg and 6 mg dry pouch lineup. The company also launched Zyn Ultra, an oral nicotine pouch with higher moisture content and free of tobacco leaf, and plans to adjust its 3 mg and 6 mg dry pouch variants to 20 pouches per can in Q4 to align with consumer preferences.On September 8, the company raised its full-year adjusted EPS guidance to $8.35-$8.50, implying 10.7%-12.7% year-over-year growth, a notable increase from the $8.11-$8.26 range issued in July. The upgraded outlook follows Zyn products receiving FDA Modified Risk Tobacco Product orders and FDA authorization for ZYN ULTRA, strengthening the product matrix and reinforcing earnings momentum.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}